Inhibikase Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Activity
Company to host conference call on Thursday, March 28, 2024 at 8:00 a.m. ETBOSTON and ATLANTA, March 27, 2024 -- Inhibikase Therapeutics, Inc. , a clinical-stage pharmaceutical company developing...
United States Risvodetinib Ik Miltonh Werner Risvodetinib Risvo Alex Lobo Stern Investor Relations Inc
Source: marketscreener.com